Artificial Neural Network for Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy
Conclusion: The proof of concept study shows that artificial neural network can significantly reduce the prediction error compared to generally population-based estimation. Artificial intelligence may provide a practical solution to improve the dosimetry-guided treatment planning for internal radionuclide therapy. 3D dosimetry including target lesions are currently under calculation to extensively test the proposed AI strategy.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Shi, K., Dong, C., Gafita, A., Zhao, Y., Tetteh, G., Menze, B., Afshar-Oromieh, A., Eiber, M., Rominger, A. Tags: Data Analysis & amp; Management Posters Source Type: research
More News: Bladder Cancer | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cardiology | CT Scan | Heart | Heart Transplant | Kidney Transplant | Liver | Liver Transplant | Lung Transplant | Men | Neurology | Nuclear Medicine | PET Scan | Prostate Cancer | Study | Urology & Nephrology